News | May 08, 2026
ICMR launches fellowship programme for biomedical scientists from developing countries
Initiative aims to strengthen South-South collaboration and capacity building in biomedical research
Initiative aims to strengthen South-South collaboration and capacity building in biomedical research
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
At the center of the deal is TERN-701, a drug recently granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration for adults with Philadelphia chromosome-positive chronic myeloid leukemia
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy
Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
Subscribe To Our Newsletter & Stay Updated
